Bianca M. Liederer

3.0k total citations
44 papers, 1.3k citations indexed

About

Bianca M. Liederer is a scholar working on Oncology, Molecular Biology and Geriatrics and Gerontology. According to data from OpenAlex, Bianca M. Liederer has authored 44 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 18 papers in Molecular Biology and 9 papers in Geriatrics and Gerontology. Recurrent topics in Bianca M. Liederer's work include Drug Transport and Resistance Mechanisms (10 papers), PARP inhibition in cancer therapy (9 papers) and Sirtuins and Resveratrol in Medicine (9 papers). Bianca M. Liederer is often cited by papers focused on Drug Transport and Resistance Mechanisms (10 papers), PARP inhibition in cancer therapy (9 papers) and Sirtuins and Resveratrol in Medicine (9 papers). Bianca M. Liederer collaborates with scholars based in United States, France and China. Bianca M. Liederer's co-authors include Ronald T. Borchardt, James Blanchard, Stefan Proniuk, Xiaorong Liang, Cornelis E. C. A. Hop, Thomas O’Brien, Deepak Sampath, Gauri Deshmukh, Yang Xiao and Jason Oeh and has published in prestigious journals such as Cell Metabolism, Clinical Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Bianca M. Liederer

42 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bianca M. Liederer United States	20	547	370	206	125	119	44	1.3k
Young G. Shin South Korea	24	975 1.8×	267 0.7×	242 1.2×	207 1.7×	72 0.6×	97	1.9k
Sushabhan Sadhukhan India	19	760 1.4×	164 0.4×	388 1.9×	38 0.3×	93 0.8×	55	1.5k
Philipp Saiko Austria	22	911 1.7×	268 0.7×	690 3.3×	60 0.5×	54 0.5×	56	1.9k
Jun Hee Lim South Korea	22	1.1k 2.0×	240 0.6×	129 0.6×	79 0.6×	38 0.3×	38	1.7k
Jerome W. Kosmeder United States	11	808 1.5×	216 0.6×	453 2.2×	89 0.7×	24 0.2×	16	1.4k
Xiaojun Feng China	29	1.1k 2.0×	162 0.4×	99 0.5×	138 1.1×	39 0.3×	58	2.4k
Andrea Galmozzi United States	19	1.0k 1.9×	160 0.4×	111 0.5×	45 0.4×	100 0.8×	31	1.8k
Jeong‐Hyeon Ko South Korea	22	1.1k 2.1×	475 1.3×	271 1.3×	197 1.6×	22 0.2×	38	2.1k
Barbara De Filippis Italy	24	755 1.4×	121 0.3×	158 0.8×	64 0.5×	70 0.6×	89	1.5k
Angelo Pugliese United States	16	586 1.1×	145 0.4×	57 0.3×	136 1.1×	211 1.8×	23	1.1k

Countries citing papers authored by Bianca M. Liederer

Since Specialization

Citations

This map shows the geographic impact of Bianca M. Liederer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bianca M. Liederer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bianca M. Liederer more than expected).

Fields of papers citing papers by Bianca M. Liederer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bianca M. Liederer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bianca M. Liederer. The network helps show where Bianca M. Liederer may publish in the future.

Co-authorship network of co-authors of Bianca M. Liederer

This figure shows the co-authorship network connecting the top 25 collaborators of Bianca M. Liederer. A scholar is included among the top collaborators of Bianca M. Liederer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bianca M. Liederer. Bianca M. Liederer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Ryan, Vikram Malhi, Bianca M. Liederer, et al.. (2023). The Absolute Bioavailability and Absorption, Metabolism, and Excretion of Ipatasertib, a Potent and Highly Selective Protein Kinase B (Akt) Inhibitor. Drug Metabolism and Disposition. 51(10). 1332–1341. 4 indexed citations

Malhi, Vikram, Nageshwar Budha, Rucha Sane, et al.. (2021). Single- and multiple-dose pharmacokinetics, potential for CYP3A inhibition, and food effect in patients with cancer and healthy subjects receiving ipatasertib. Cancer Chemotherapy and Pharmacology. 88(6). 921–930. 4 indexed citations

Durk, Matthew R., et al.. (2018). Use of Subcutaneous and Intraperitoneal Administration Methods to Facilitate Cassette Dosing in Microdialysis Studies in Rats. Drug Metabolism and Disposition. 46(7). 964–969. 11 indexed citations

Daemen, Anneleen, Bonnie Liu, Mandy Kwong, et al.. (2018). Pan-Cancer Metabolic Signature Predicts Co-Dependency on Glutaminase and De Novo Glutathione Synthesis Linked to a High-Mesenchymal Cell State. Cell Metabolism. 28(3). 383–399.e9. 56 indexed citations

Misner, Dinah, M. Ariel Kauss, Jatinder Singh, et al.. (2016). Cardiotoxicity Associated with Nicotinamide Phosphoribosyltransferase Inhibitors in Rodents and in Rat and Human-Derived Cells Lines. Cardiovascular Toxicology. 17(3). 307–318. 18 indexed citations

Poulin, Patrick, Yung‐Hsiang Chen, Xiao Ding, et al.. (2015). Prediction of Drug Distribution in Subcutaneous Xenografts of Human Tumor Cell Lines and Healthy Tissues in Mouse: Application of the Tissue Composition-Based Model to Antineoplastic Drugs. Journal of Pharmaceutical Sciences. 104(4). 1508–1521. 22 indexed citations

Shames, David S., Kristi Elkins, Kimberly Walter, et al.. (2013). Loss of NAPRT1 Expression by Tumor-Specific Promoter Methylation Provides a Novel Predictive Biomarker for NAMPT Inhibitors. Clinical Cancer Research. 19(24). 6912–6923. 59 indexed citations

Xiao, Yang, Kristi Elkins, Jenni Durieux, et al.. (2013). Dependence of Tumor Cell Lines and Patient-Derived Tumors on the NAD Salvage Pathway Renders Them Sensitive to NAMPT Inhibition with GNE-618. Neoplasia. 15(10). 1151–IN23. 64 indexed citations

Dragovich, Peter S., Kenneth W. Bair, Yen‐Ching Ho, et al.. (2013). Identification of 2,3-dihydro-1H-pyrrolo[3,4-c]pyridine-derived ureas as potent inhibitors of human nicotinamide phosphoribosyltransferase (NAMPT). Bioorganic & Medicinal Chemistry Letters. 23(17). 4875–4885. 22 indexed citations

10.

Zou, Peng, Xingrong Liu, Susan Wong, Meihua Rose Feng, & Bianca M. Liederer. (2013). Comparison of In Vitro-In Vivo Extrapolation of Biliary Clearance Using an Empirical Scaling Factor Versus Transport-Based Scaling Factors in Sandwich-Cultured Rat Hepatocytes. Journal of Pharmaceutical Sciences. 102(8). 2837–2850. 16 indexed citations

11.

Poulin, Patrick, Donna M. Dambach, Kevin A. Ford, et al.. (2013). An Algorithm for Evaluating Potential Tissue Drug Distribution in Toxicology Studies from Readily Available Pharmacokinetic Parameters. Journal of Pharmaceutical Sciences. 102(10). 3816–3829. 9 indexed citations

12.

O’Brien, Thomas, Jason Oeh, Yang Xiao, et al.. (2013). Supplementation of Nicotinic Acid with NAMPT Inhibitors Results in Loss of In Vivo Efficacy in NAPRT1-Deficient Tumor Models. Neoplasia. 15(12). 1314–IN3. 47 indexed citations

13.

Diaz, Dolores, Kevin A. Ford, Dylan P. Hartley, et al.. (2012). Pharmacokinetic drivers of toxicity for basic molecules: Strategy to lower pKa results in decreased tissue exposure and toxicity for a small molecule Met inhibitor. Toxicology and Applied Pharmacology. 266(1). 86–94. 22 indexed citations

14.

Liu, Xingrong, Xiao Ding, Gauri Deshmukh, Bianca M. Liederer, & Cornelis E. C. A. Hop. (2012). Use of the Cassette-Dosing Approach to Assess Brain Penetration in Drug Discovery. Drug Metabolism and Disposition. 40(5). 963–969. 37 indexed citations

15.

Liederer, Bianca M., Xingrong Liu, Leonid M. Berezhkovskiy, et al.. (2011). Preclinical stereoselective disposition and toxicokinetics of two novel MET inhibitors. Xenobiotica. 42(5). 456–465. 1 indexed citations

16.

Liederer, Bianca M., Leonid M. Berezhkovskiy, Brian J. Dean, et al.. (2010). Preclinical absorption, distribution, metabolism, excretion, and pharmacokinetic–pharmacodynamic modelling ofN-(4-(3-((3S,4R)-1-ethyl-3-fluoropiperidine-4-ylamino)-1H-pyrazolo[3,4-b]pyridin-4-yloxy)-3-fluorophenyl)-2-(4-fluorophenyl)-3-oxo-2,3-dihydropyridazine-4-carboxamide, a novel MET kinase inhibitor. Xenobiotica. 41(4). 327–339. 7 indexed citations

17.

Liederer, Bianca M. & Ronald T. Borchardt. (2006). Enzymes involved in the bioconversion of ester-based prodrugs. Journal of Pharmaceutical Sciences. 95(6). 1177–1195. 304 indexed citations

18.

Liederer, Bianca M., et al.. (2005). Significant differences in the disposition of cyclic prodrugs of opioid peptides in rats and guinea pigs following IV administration. Journal of Pharmaceutical Sciences. 94(12). 2676–2687. 10 indexed citations

19.

Proniuk, Stefan, et al.. (2002). Topical Formulation Studies with DEET (N,N‐Diethyl‐3‐methylbenzamide) and Cyclodextrins. Journal of Pharmaceutical Sciences. 91(1). 101–110. 16 indexed citations

20.

Proniuk, Stefan, Bianca M. Liederer, & James Blanchard. (2002). Preformulation Study of Epigallocatechin Gallate, a Promising Antioxidant for Topical Skin Cancer Prevention. Journal of Pharmaceutical Sciences. 91(1). 111–116. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact